Harel Insurance Investments & Financial Services’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-210	Closed	-$13K	–	491
2018 Q1	$13K	Buy	+210	New	+$13.8K	﹤0.01%	411
2017 Q4	–	Sell	-210	Closed	-$13.5K	–	420
2017 Q3	$14K	Buy	+210	New	+$13.3K	﹤0.01%	371
2017 Q2	–	Sell	-210	Closed	-$12.6K	–	381
2017 Q1	$12K	Buy	+210	New	+$12.3K	﹤0.01%	375
2016 Q4	–	Hold	0	–	–	–	293
2016 Q3	–	Hold	0	–	–	–	366
2016 Q2	–	Hold	0	–	–	–	535
2016 Q1	–	Hold	0	–	–	–	330

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Harel Insurance Investments & Financial Services's PJP Position: Q2 2018 in Review

Harel Insurance Investments & Financial Services sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2018, closing a stake of 210 shares — an estimated $13K sold.

Harel Insurance Investments & Financial Services first reported a position in PJP in Q1 2017 and held it in 3 quarters. The position peaked at $14K in Q3 2017. 86 funds tracked by Wall St. Rank hold PJP as of Q2 2018.

Harel Insurance Investments & Financial Services reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2018 after selling out during the quarter.
Harel Insurance Investments & Financial Services sold 210 Invesco Pharmaceuticals ETF shares in Q2 2018, an estimated $13K.
Harel Insurance Investments & Financial Services first reported a position in Invesco Pharmaceuticals ETF in Q1 2017 and held it in 3 quarters.
Harel Insurance Investments & Financial Services's Invesco Pharmaceuticals ETF position peaked at $14K in Q3 2017.
86 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2018.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2018, filed 30 Jul 2018.